Company Filing History:
2 out of 3 
1 out of 2,939 
1 out of 1 Years Active: 1988-1999
Title: Asgar Electricwala: Innovator in Thrombotic Treatment
Introduction
Asgar Electricwala is a notable inventor based in Salisbury, GB. He has made significant contributions to the field of medicine, particularly in the treatment of thrombotic events. With a total of 4 patents to his name, Electricwala's work has the potential to impact patient care and treatment options.
Latest Patents
One of his latest patents focuses on the treatment of thrombotic events. This method aims to prevent the formation of platelet-rich clots or thrombus and to deaggregate existing clots using hementin, a polypeptide derived from leech salivary glands. Hementin can be administered in a pharmaceutically acceptable carrier or excipient, with or without additional anticoagulants such as hirudin, hirudin analogues, or an inhibitor of factor Xa. Another patent he holds is related to anti-thrombins, further showcasing his expertise in this critical area of medical innovation.
Career Highlights
Throughout his career, Electricwala has worked with reputable companies, including Biopharm (UK) Limited and Merck Patent GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Asgar Electricwala has collaborated with notable individuals in his field, including Anthony Atkinson and Roy T. Sawyer. These partnerships have likely enriched his work and expanded the impact of his inventions.
Conclusion
Asgar Electricwala is a distinguished inventor whose work in thrombotic treatment is paving the way for new medical solutions. His innovative patents and collaborations highlight his commitment to improving patient outcomes in the field of medicine.